Associated Papers
[MACULOPAPULAR CUTANEOUS MASTOCYTOSIS HARBORING A KIT MUTATION (ASP419DEL): A CASE REPORT].
Fukaura A et al.
Arerugi = [allergy], 2024
Clinical Application of Comprehensive Genomic Profiling Tests for Diffuse Gliomas.
Omura T et al.
Cancers, 2022
35626060 (PubMed )
Supplement: cancers-14-02454-s001.zip › cancers-1674301-SI.xlsx › VUS
Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer.
Hagio K et al.
Scientific Reports, 2021
Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations.
Kasai F et al.
Human Cell, 2020
32180206 (PubMed )
Supplement: 13577_2020_347_MOESM1_ESM.pdf
Genotype and phenotype analysis of patients with pediatric cutaneous mastocytosis, especially wild-type KIT patients.
Arase N et al.
The Journal of Dermatology, 2020
Germline Variants of Prostate Cancer in Japanese Families.
Hayano T et al.
Plos One, 2016
27701467 (PubMed )
Supplement: pone.0164233.s005.xlsx › Table_S5
Rare FLT3 deletion mutants may provide additional treatment options to patients with AML: an approach to individualized medicine.
Chatain N et al.
Leukemia, 2015
Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing.
Takenaka M et al.
International Journal of Oncology, 2015
WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group.
Sano H et al.
International Journal of Hematology, 2013
Select a paper to view details